Commensal Fungi in Health and Disease

Cell Host and Microbe

Volumn 22, Issue 2, 2017, Pages 156-165

  Limon, Jose J ^a   Skalski, Joseph H ^a,b   Underhill, David M ^a,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Candida; commensal fungi; microbiome; mycobiome

Indexed keywords

BACTERIAL FLORA; COMMENSAL; DISEASES; DYSBIOSIS; FUNGAL COMMUNITY; FUNGUS; GASTROINTESTINAL TRACT; HEALTH; HOST; HUMAN; IMMUNITY; LUNG DISEASE; METABOLIC DISORDER; MICROBIAL DIVERSITY; MICROFLORA; MOUTH CAVITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; SKIN; SKIN DISEASE; UROGENITAL SYSTEM; BACTERIUM; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLIC SYNDROME X; MICROBIOLOGY; MUCOSAL IMMUNITY; ORGANISMAL INTERACTION; PHYSIOLOGY; SYMBIOSIS;

FUNGAL DNA;

BACTERIA; DNA, FUNGAL; DYSBIOSIS; FUNGI; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; LUNG DISEASES; METABOLIC SYNDROME; MICROBIAL INTERACTIONS; MICROBIOTA; RESPIRATORY SYSTEM; SKIN; SKIN DISEASES; SYMBIOSIS; UROGENITAL SYSTEM;

EID: 85030476886     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.07.002     Document Type: Review

References (88)

1. Bliss, J.M., Basavegowda, K.P., Watson, W.J., Sheikh, A.U., Ryan, R.M., Vertical and horizontal transmission of Candida albicans in very low birth weight infants using DNA fingerprinting techniques. Pediatr. Infect. Dis. J. 27 (2008), 231–235.
2. Bokulich, N.A., Mills, D.A., Improved selection of internal transcribed spacer-specific primers enables quantitative, ultra-high-throughput profiling of fungal communities. Appl. Environ. Microbiol. 79 (2013), 2519–2526.
3. Brunetti, L., De Caro, F., Boccia, G., Cavallo, P., Capunzo, M., Surveillance of nosocomial infections: a preliminary study on yeast carriage on hands of healthcare workers. J. Prev. Med. Hyg. 49 (2008), 63–68.
4. Burge, H.A., An update on pollen and fungal spore aerobiology. J. Allergy Clin. Immunol. 110 (2002), 544–552.
5. Buts, J.P., Dekeyser, N., Stilmant, C., Delem, E., Smets, F., Sokal, E., Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr. Res. 60 (2006), 24–29.
6. Cabello, H., Torres, A., Celis, R., El-Ebiary, M., Puig de la Bellacasa, J., Xaubet, A., Gonzalez, J., Agusti, C., Soler, N., Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur. Respir. J. 10 (1997), 1137–1144.
7. Cassone, A., Cauda, R., Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders. AIDS 26 (2012), 1457–1472.
8. Castagliuolo, I., Riegler, M.F., Valenick, L., LaMont, J.T., Pothoulakis, C., Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun 67 (1999), 302–307.
9. Chan, A.S., Jonas, A.B., Qiu, X., Ottoson, N.R., Walsh, R.M., Gorden, K.B., Harrison, B., Maimonis, P.J., Leonardo, S.M., Ertelt, K.E., et al. Imprime PGG-mediated anti-cancer immune activation requires immune complex formation. PLoS One, 11, 2016, e0165909.
10. Charlson, E.S., Diamond, J.M., Bittinger, K., Fitzgerald, A.S., Yadav, A., Haas, A.R., Bushman, F.D., Collman, R.G., Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am. J. Respir. Crit. Care Med. 186 (2012), 536–545.
11. Chehoud, C., Albenberg, L.G., Judge, C., Hoffmann, C., Grunberg, S., Bittinger, K., Baldassano, R.N., Lewis, J.D., Bushman, F.D., Wu, G.D., Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm. Bowel Dis. 21 (2015), 1948–1956.
12. Chiaro, T.R., Soto, R., Zac Stephens, W., Kubinak, J.L., Petersen, C., Gogokhia, L., Bell, R., Delgado, J.C., Cox, J., Voth, W., et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci. Transl. Med., 9, 2017, 10.1126/scitranslmed.aaf9044.
13. Cui, L., Morris, A., Ghedin, E., The human mycobiome in health and disease. Genome Med., 5, 2013, 63.
14. Cui, L., Lucht, L., Tipton, L., Rogers, M.B., Fitch, A., Kessinger, C., Camp, D., Kingsley, L., Leo, N., Greenblatt, R.M., et al. Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease. Am. J. Respir. Crit. Care Med. 191 (2015), 932–942.
15. Delhaes, L., Monchy, S., Frealle, E., Hubans, C., Salleron, J., Leroy, S., Prevotat, A., Wallet, F., Wallaert, B., Dei-Cas, E., et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community – implications for therapeutic management. PLoS One, 7, 2012, e36313.
16. Devaraj, S., Hemarajata, P., Versalovic, J., The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin. Chem. 59 (2013), 617–628.
17. Dickson, R.P., Erb-Downward, J.R., Freeman, C.M., McCloskey, L., Falkowski, N.R., Huffnagle, G.B., Curtis, J.L., Bacterial topography of the healthy human lower respiratory tract. MBio, 8, 2017, 10.1128/mBio.02287-16.
18. Dollive, S., Chen, Y.Y., Grunberg, S., Bittinger, K., Hoffmann, C., Vandivier, L., Cuff, C., Lewis, J.D., Wu, G.D., Bushman, F.D., Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One, 8, 2013, e71806.
19. Drell, T., Lillsaar, T., Tummeleht, L., Simm, J., Aaspollu, A., Vain, E., Saarma, I., Salumets, A., Donders, G.G., Metsis, M., Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women. PLoS One, 8, 2013, e54379.
20. Dupuy, A.K., David, M.S., Li, L., Heider, T.N., Peterson, J.D., Montano, E.A., Dongari-Bagtzoglou, A., Diaz, P.I., Strausbaugh, L.D., Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS One, 9, 2014, e90899.
21. Erb Downward, J.R., Falkowski, N.R., Mason, K.L., Muraglia, R., Huffnagle, G.B., Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans. Sci. Rep., 3, 2013, 2191.
22. Fan, D., Coughlin, L.A., Neubauer, M.M., Kim, J., Kim, M.S., Zhan, X., Simms-Waldrip, T.R., Xie, Y., Hooper, L.V., Koh, A.Y., Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med. 21 (2015), 808–814.
23. Findley, K., Oh, J., Yang, J., Conlan, S., Deming, C., Meyer, J.A., Schoenfeld, D., Nomicos, E., Park, M., NIH Intramural Sequencing Center Comparative Sequencing Program, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature 498 (2013), 367–370.
24. Fujimura, K.E., Sitarik, A.R., Havstad, S., Lin, D.L., Levan, S., Fadrosh, D., Panzer, A.R., LaMere, B., Rackaityte, E., Lukacs, N.W., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med. 22 (2016), 1187–1191.
25. Gaitanis, G., Magiatis, P., Hantschke, M., Bassukas, I.D., Velegraki, A., The Malassezia genus in skin and systemic diseases. Clin. Microbiol. Rev. 25 (2012), 106–141.
26. Garrow, J.S., Webster, J., Quetelet's index (W/H2) as a measure of fatness. Int. J. Obes. 9 (1985), 147–153.
27. Ghannoum, M.A., Jurevic, R.J., Mukherjee, P.K., Cui, F., Sikaroodi, M., Naqvi, A., Gillevet, P.M., Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog., 6, 2010, e1000713.
28. Halwachs, B., Madhusudhan, N., Krause, R., Nilsson, R.H., Moissl-Eichinger, C., Hogenauer, C., Thallinger, G.G., Gorkiewicz, G., Critical issues in mycobiota analysis. Front. Microbiol., 8, 2017, 180.
29. Hoarau, G., Mukherjee, P.K., Gower-Rousseau, C., Hager, C., Chandra, J., Retuerto, M.A., Neut, C., Vermeire, S., Clemente, J., Colombel, J.F., et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease. MBio, 7, 2016, 10.1128/mBio.01250-16.
30. Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G.D., Lewis, J.D., Bushman, F.D., Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One, 8, 2013, e66019.
31. Hong, F., Yan, J., Baran, J.T., Allendorf, D.J., Hansen, R.D., Ostroff, G.R., Xing, P.X., Cheung, N.K., Ross, G.D., Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173 (2004), 797–806.
32. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
33. Iliev, I.D., Funari, V.A., Taylor, K.D., Nguyen, Q., Reyes, C.N., Strom, S.P., Brown, J., Becker, C.A., Fleshner, P.R., Dubinsky, M., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336 (2012), 1314–1317.
34. Iliev, I.D., Underhill, D.M., Striking a balance: fungal commensalism versus pathogenesis. Curr. Opin. Microbiol. 16 (2013), 366–373.
35. Irinyi, L., Serena, C., Garcia-Hermoso, D., Arabatzis, M., Desnos-Ollivier, M., Vu, D., Cardinali, G., Arthur, I., Normand, A.C., Giraldo, A., et al. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med. Mycol. 53 (2015), 313–337.
36. Ishikawa, T., Itoh, F., Yoshida, S., Saijo, S., Matsuzawa, T., Gonoi, T., Saito, T., Okawa, Y., Shibata, N., Miyamoto, T., Yamasaki, S., Identification of distinct ligands for the C-type lectin receptors Mincle and Dectin-2 in the pathogenic fungus Malassezia. Cell Host Microbe 13 (2013), 477–488.
37. Jo, J.H., Deming, C., Kennedy, E.A., Conlan, S., Polley, E.C., Ng, W.L., Program, N.C.S., Segre, J.A., Kong, H.H., Diverse human skin fungal communities in children converge in adulthood. J. Invest. Dermatol. 136 (2016), 2356–2363.
38. Joossens, S., Reinisch, W., Vermeire, S., Sendid, B., Poulain, D., Peeters, M., Geboes, K., Bossuyt, X., Vandewalle, P., Oberhuber, G., et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 122 (2002), 1242–1247.
39. Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson, C.A., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
40. Kalan, L., Loesche, M., Hodkinson, B.P., Heilmann, K., Ruthel, G., Gardner, S.E., Grice, E.A., Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. MBio, 7, 2016, 10.1128/mBio.01058-16.
41. Kelesidis, T., Pothoulakis, C., Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap. Adv. Gastroenterol. 5 (2012), 111–125.
42. Khatri, I., Tomar, R., Ganesan, K., Prasad, G.S., Subramanian, S., Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii. Sci. Rep., 7, 2017, 371.
43. Kim, Y.G., Udayanga, K.G., Totsuka, N., Weinberg, J.B., Nunez, G., Shibuya, A., Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE(2). Cell Host Microbe 15 (2014), 95–102.
44. Klein, R.S., Harris, C.A., Small, C.B., Moll, B., Lesser, M., Friedland, G.H., Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311 (1984), 354–358.
45. Kohler, J.R., Casadevall, A., Perfect, J., The spectrum of fungi that infects humans. Cold Spring Harb. Perspect. Med., 5, 2014, a019273.
46. Koljalg, U., Nilsson, R.H., Abarenkov, K., Tedersoo, L., Taylor, A.F., Bahram, M., Bates, S.T., Bruns, T.D., Bengtsson-Palme, J., Callaghan, T.M., et al. Towards a unified paradigm for sequence-based identification of fungi. Mol. Ecol. 22 (2013), 5271–5277.
47. Kramer, R., Sauer-Heilborn, A., Welte, T., Guzman, C.A., Abraham, W.R., Hofle, M.G., Cohort study of airway mycobiome in adult cystic fibrosis patients: differences in community structure between fungi and bacteria reveal predominance of transient fungal elements. J. Clin. Microbiol. 53 (2015), 2900–2907.
48. Latge, J.P., Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12 (1999), 310–350.
49. Lewis, J.D., Chen, E.Z., Baldassano, R.N., Otley, A.R., Griffiths, A.M., Lee, D., Bittinger, K., Bailey, A., Friedman, E.S., Hoffmann, C., et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 18 (2015), 489–500.
50. Li, K., Bihan, M., Yooseph, S., Methe, B.A., Analyses of the microbial diversity across the human microbiome. PLoS One, 7, 2012, e32118.
51. Liguori, G., Lamas, B., Richard, M.L., Brandi, G., da Costa, G., Hoffmann, T.W., Di Simone, M.P., Calabrese, C., Poggioli, G., Langella, P., et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients. J. Crohns Colitis 10 (2016), 296–305.
52. Ma, J., Prince, A.L., Bader, D., Hu, M., Ganu, R., Baquero, K., Blundell, P., Alan Harris, R., Frias, A.E., Grove, K.L., Aagaard, K.M., High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat. Commun., 5, 2014, 3889.
53. Mar Rodriguez, M., Perez, D., Javier Chaves, F., Esteve, E., Marin-Garcia, P., Xifra, G., Vendrell, J., Jove, M., Pamplona, R., Ricart, W., et al. Obesity changes the human gut mycobiome. Sci. Rep., 5, 2015, 14600.
54. Mason, K.L., Erb Downward, J.R., Mason, K.D., Falkowski, N.R., Eaton, K.A., Kao, J.Y., Young, V.B., Huffnagle, G.B., Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect. Immun. 80 (2012), 3371–3380.
55. Motooka, D., Fujimoto, K., Tanaka, R., Yaguchi, T., Gotoh, K., Maeda, Y., Furuta, Y., Kurakawa, T., Goto, N., Yasunaga, T., et al. Fungal ITS1 deep-sequencing strategies to reconstruct the composition of a 26-species community and evaluation of the gut mycobiota of healthy Japanese individuals. Front. Microbiol., 8, 2017, 238.
56. Mukherjee, P.K., Chandra, J., Retuerto, M., Sikaroodi, M., Brown, R.E., Jurevic, R., Salata, R.A., Lederman, M.M., Gillevet, P.M., Ghannoum, M.A., Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog., 10, 2014, e1003996.
57. Nilsson, R.H., Ryberg, M., Kristiansson, E., Abarenkov, K., Larsson, K.H., Koljalg, U., Taxonomic reliability of DNA sequences in public sequence databases: a fungal perspective. PLoS One, 1, 2006, e59.
58. Noverr, M.C., Falkowski, N.R., McDonald, R.A., McKenzie, A.N., Huffnagle, G.B., Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 73 (2005), 30–38.
59. Ott, S.J., Kuhbacher, T., Musfeldt, M., Rosenstiel, P., Hellmig, S., Rehman, A., Drews, O., Weichert, W., Timmis, K.N., Schreiber, S., Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand. J. Gastroenterol. 43 (2008), 831–841.
60. Paulino, L.C., Tseng, C.H., Strober, B.E., Blaser, M.J., Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J. Clin. Microbiol. 44 (2006), 2933–2941.
61. Prohic, A., Jovovic Sadikovic, T., Krupalija-Fazlic, M., Kuskunovic-Vlahovljak, S., Malassezia species in healthy skin and in dermatological conditions. Int. J. Dermatol. 55 (2016), 494–504.
62. Qamar, A., Aboudola, S., Warny, M., Michetti, P., Pothoulakis, C., LaMont, J.T., Kelly, C.P., Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect. Immun. 69 (2001), 2762–2765.
63. Ribbing, C., Engblom, C., Lappalainen, J., Lindstedt, K., Kovanen, P.T., Karlsson, M.A., Lundeberg, L., Johansson, C., Nilsson, G., Lunderius-Andersson, C., Scheynius, A., Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin-1 expression. Allergy 66 (2011), 110–119.
64. Saber, A., Alipour, B., Faghfoori, Z., Yari Khosroushahi, A., Cellular and molecular effects of yeast probiotics on cancer. Crit. Rev. Microbiol. 43 (2017), 96–115.
65. Scalabrin, D.M., Bavbek, S., Perzanowski, M.S., Wilson, B.B., Platts-Mills, T.A., Wheatley, L.M., Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J. Allergy Clin. Immunol. 104 (1999), 1273–1279.
66. Schoch, C.L., Seifert, K.A., Huhndorf, S., Robert, V., Spouge, J.L., Levesque, C.A., Chen, W. Fungal Barcoding Consortium, Fungal Barcoding Consortium Author List. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc. Natl. Acad. Sci. USA 109 (2012), 6241–6246.
67. Schubert, K., Groenewald, J.Z., Braun, U., Dijksterhuis, J., Starink, M., Hill, C.F., Zalar, P., de Hoog, G.S., Crous, P.W., Biodiversity in the Cladosporium herbarum complex (Davidiellaceae, Capnodiales), with standardisation of methods for Cladosporium taxonomy and diagnostics. Stud. Mycol. 58 (2007), 105–156.
68. Stoltz, D.A., Meyerholz, D.K., Welsh, M.J., Origins of cystic fibrosis lung disease. N. Engl. J. Med. 372 (2015), 351–362.
69. Sokol, H., Leducq, V., Aschard, H., Pham, H.P., Jegou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion-Larmurier, I., et al. Fungal microbiota dysbiosis in IBD. Gut 66 (2016), 1039–1048.
70. Sudfeld, C.R., Dasenbrook, E.C., Merz, W.G., Carroll, K.C., Boyle, M.P., Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. J. Cyst. Fibros. 9 (2010), 110–116.
71. Takata, K., Tomita, T., Okuno, T., Kinoshita, M., Koda, T., Honorat, J.A., Takei, M., Hagihara, K., Sugimoto, T., Mochizuki, H., et al. Dietary yeasts reduce inflammation in central nerve system via microflora. Ann. Clin. Transl. Neurol. 2 (2015), 56–66.
72. Tang, J., Iliev, I.D., Brown, J., Underhill, D.M., Funari, V.A., Mycobiome: approaches to analysis of intestinal fungi. J. Immunol. Methods 421 (2015), 112–121.
73. Thomas, M., Sadjadian, P., Kollmeier, J., Lowe, J., Mattson, P., Trout, J.R., Gargano, M., Patchen, M.L., Walsh, R., Beliveau, M., et al. A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer. Invest. New Drugs 35 (2017), 345–358.
74. Thomas, S., Izard, J., Walsh, E., Batich, K., Chongsathidkiet, P., Clarke, G., Sela, D.A., Muller, A.J., Mullin, J.M., Albert, K., et al. The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists. Cancer Res. 77 (2017), 1783–1812.
75. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
76. Valenza, G., Tappe, D., Turnwald, D., Frosch, M., Konig, C., Hebestreit, H., Abele-Horn, M., Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J. Cyst. Fibros. 7 (2008), 123–127.
77. van Woerden, H.C., Gregory, C., Brown, R., Marchesi, J.R., Hoogendoorn, B., Matthews, I.P., Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect. Dis., 13, 2013, 69.
78. Velegraki, A., Cafarchia, C., Gaitanis, G., Iatta, R., Boekhout, T., Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS Pathog., 11, 2015, e1004523.
79. Vesty, A., Biswas, K., Taylor, M.W., Gear, K., Douglas, R.G., Evaluating the impact of DNA extraction method on the representation of human oral bacterial and fungal communities. PLoS One, 12, 2017, e0169877.
80. Volman, J.J., Ramakers, J.D., Plat, J., Dietary modulation of immune function by beta-glucans. Physiol. Behav. 94 (2008), 276–284.
81. Wheeler, M.L., Limon, J.J., Bar, A.S., Leal, C.A., Gargus, M., Tang, J., Brown, J., Funari, V.A., Wang, H.L., Crother, T.R., et al. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe 19 (2016), 865–873.
82. White, P.L., Price, J.S., Posso, R.B., Barnes, R.A., An evaluation of the performance of the Dynamiker(R) fungus (1-3)-beta-D-glucan assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia. Med. Mycol., 2017, 10.1093/mmy/myx004 Published online March 3, 2017.
83. Willger, S.D., Grim, S.L., Dolben, E.L., Shipunova, A., Hampton, T.H., Morrison, H.G., Filkins, L.M., O'Toole, G.A., Moulton, L.A., Ashare, A., et al. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome, 2, 2014, 40.
84. Xavier, R.J., Podolsky, D.K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007), 427–434.
85. Yamasaki, S., Matsumoto, M., Takeuchi, O., Matsuzawa, T., Ishikawa, E., Sakuma, M., Tateno, H., Uno, J., Hirabayashi, J., Mikami, Y., et al. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc. Natl. Acad. Sci. USA 106 (2009), 1897–1902.
86. Yang, A.M., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., Koyama, Y., et al. Intestinal fungi contribute to development of alcoholic liver disease. J. Clin. Invest. 127 (2017), 2829–2841.
87. Yu, L., Zhao, X.K., Cheng, M.L., Yang, G.Z., Wang, B., Liu, H.J., Hu, Y.X., Zhu, L.L., Zhang, S., Xiao, Z.W., et al. Saccharomyces boulardii administration changes gut microbiota and attenuates D-galactosamine-induced liver injury. Sci. Rep., 7, 2017, 1359.
88. Zhang, Z., Li, J., Zheng, W., Zhao, G., Zhang, H., Wang, X., Guo, Y., Qin, C., Shi, Y., Peripheral lymphoid volume expansion and maintenance are controlled by gut microbiota via RALDH+ dendritic cells. Immunity 44 (2016), 330–342.